Steven Swendeman

3.3k citations

35 papers · 2.6k indexed · h-index 27

Impact in

Immunology and Allergy top 2%
- Cell Adhesion Molecules Research
Molecular Biology top 5%
- Sphingolipid Metabolism and Signaling
- Histone Deacetylase Inhibitors Research
- Lipid Membrane Structure and Behavior

Papers in

Immunology and Allergy 3
- Cell Adhesion Molecules Research 3
Ophthalmology 4
- Retinal Diseases and Treatments 4

Co-authors: David A. Thorley‐Lawson M Sheffery Timothy Hla Carl Blobel Michael P. LaQuaglia Victoria A. Blaho Sylvain Galvani L C Lim
Journals: Journal of Biological Chemistry (5 papers)Molecular and Cellular Biology (5 papers)Science Signaling (2 papers)Investigative Ophthalmology & Visual Science (1 paper)Surgery (1 paper)
Partner nations: United States Germany Japan

In The Last Decade

Steven Swendeman

35 papers receiving 2.6k citations

Peers

Countries citing papers authored by Steven Swendeman

Since Specialization

Citations

This map shows the geographic impact of Steven Swendeman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Steven Swendeman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Steven Swendeman more than expected).

Fields of papers citing papers by Steven Swendeman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Steven Swendeman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Steven Swendeman. The network helps show where Steven Swendeman may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Steven Swendeman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Steven Swendeman Line = papers co-authored together Steven Swendeman links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Therapeutic activation of endothelial sphingosine‐1‐phosphate receptor 1 by chaperone‐bound S1P suppresses proliferative retinal neovascularization EMBO Molecular Medicine ·Colin Niaudet, B. Jung, Andrew Kuo, Steven Swendeman, Australia and Canada David B. MacDonald United States, Ennica Ntlemo, 瓜生拓也, Zhongjie Fu, Lois E. H. Smith, Timothy Hla	2023	13
2	Plasma components to protect the endothelial barrier after shock: A role for sphingosine 1-phosphate Surgery ·Lawrence N. Diebel, David M. Liberati, Timothy Hla, Steven Swendeman	2021	3
3	Sphingosine 1-Phosphate Receptor Signaling Establishes AP-1 Gradients to Allow for Retinal Endothelial Cell Specialization Developmental Cell ·K. Yanagida, Eric Engelbrecht, Colin Niaudet, B. Jung, Konstantin Gaengel, Kristina M. Holton, Steven Swendeman, Catherine H. Liu, Cynthia Ursino, Andrew Kuo, Zhongjie Fu, Lois E. H. Smith, Christer Betsholtz, Timothy Hla	2020	40
4	Identification of ApoA4 as a sphingosine 1-phosphate chaperone in ApoM- and albumin-deficient mice Journal of Lipid Research ·Hideru Obinata, Andrew Kuo, Mahalingam, Steven Swendeman, Catherine H. Liu, Victoria A. Blaho, J Viehoff, Kenichi Satoh, Takashi Izumi, Timothy Hla	2019	38
5	Sphingosine 1‐Phosphate Receptor 1 Signaling Maintains Endothelial Cell Barrier Function and Protects Against Immune Complex–Induced Vascular Injury Arthritis & Rheumatology ·Nathalie Burg, Steven Swendeman, Stefan Worgall, Timothy Hla, Jane E. Salmon	2018	71
6	An engineered S1P chaperone attenuates hypertension and ischemic injury Science Signaling ·Steven Swendeman, Yuquan Xiong, Anna Cantalupo, Hui Yuan, Nathalie Burg, Yu Hisano, Andréane Cartier, Catherine H. Liu, Eric Engelbrecht, Victoria A. Blaho, Yi Zhang, K. Yanagida, Sylvain Galvani, Hideru Obinata, Jane E. Salmon, Teresa Sánchez, Annarita Di Lorenzo, Timothy Hla	2017	85
7	HDL activation of endothelial sphingosine-1-phosphate receptor-1 (S1P1) promotes regeneration and suppresses fibrosis in the liver JCI Insight ·Bi‐Sen Ding, Catherine H. Liu, Youjing Wang, Yutian Chen, Steven Swendeman, B. Jung, Deebly Chavez, Zhongwei Cao, Christina Christoffersen, Lars B. Nielsen, Susan R. Schwab, Shahin Rafii, Timothy Hla	2016	61
8	HDL-bound sphingosine 1-phosphate acts as a biased agonist for the endothelial cell receptor S1P ₁ to limit vascular inflammation Science Signaling ·Sylvain Galvani, Marie Sanson, Victoria A. Blaho, Steven Swendeman, Hideru Obinata, E. Filippelli, Björn Dahlbäck, Mari Kono, Richard L. Proia, Jonathan D. Smith, Timothy Hla	2015	252
9	HDL-bound sphingosine-1-phosphate restrains lymphopoiesis and neuroinflammation Nature ·Victoria A. Blaho, Sylvain Galvani, Eric Engelbrecht, Catherine Liu, Steven Swendeman, Mari Kono, Richard L. Proia, Lawrence Steinman, May Han, Timothy Hla	2015	182
10	iRHOM2 is a critical pathogenic mediator of inflammatory arthritis Journal of Clinical Investigation ·Priya D. Issuree, Thorsten Maretzky, David R. McIlwain, Sébastien Monette, Xiaoping Qing, Philipp A. Lang, Steven Swendeman, Kyung-Hyun Park-Min, Nikolaus B. Binder, George D. Kalliolias, Anna Yarilina, Keisuke Horiuchi, Lionel B. Ivashkiv, Tak W. Mak, Jane E. Salmon, Carl Blobel	2013	128
11	Migration of growth factor-stimulated epithelial and endothelial cells depends on EGFR transactivation by ADAM17 Nature Communications ·Thorsten Maretzky, Astrid Evers, Wenhui Zhou, Steven Swendeman, Pui‐Mun Wong, Shahin Rafii, Karina Reiß, Carl Blobel	2011	124
12	Stimulation of Platelet-derived Growth Factor Receptor β (PDGFRβ) Activates ADAM17 and Promotes Metalloproteinase-dependent Cross-talk between the PDGFRβ and Epidermal Growth Factor Receptor (EGFR) Signaling Pathways Journal of Biological Chemistry ·Karen Mendelson, Steven Swendeman, Paul Säftig, Carl Blobel	2010	43
13	ADAM8 is a negative regulator of retinal neovascularization and of the growth of heterotopically injected tumor cells in mice Journal of Molecular Medicine ·Victor H. Guaiquil, Steven Swendeman, Wenhui Zhou, Jl. Santoni, Gisela Weskamp, Jörg W. Bartsch, Carl Blobel	2010	43
14	VEGF-A Stimulates ADAM17-Dependent Shedding of VEGFR2 and Crosstalk Between VEGFR2 and ERK Signaling Circulation Research ·Steven Swendeman, Karen Mendelson, Gisela Weskamp, Keisuke Horiuchi, Urban Deutsch, Peggy Scherle, Andrea T. Hooper, Shahin Rafii, Carl Blobel	2008	138
15	ADAM10 is a principal 'sheddase' of the low-affinity immunoglobulin E receptor CD23 Nature Immunology ·Gisela Weskamp, Jill Ford, Jamie Sturgill, Steve L. Martin, Andrew Docherty, Steven Swendeman, Neil Broadway, Dieter Hartmann, Paul Säftig, Shelby P. Umland, Atsuko Sehara‐Fujisawa, Roy A. Black, Andreas Ludwig, J. David Becherer, Daniel H. Conrad, Carl Blobel	2006	162
16	Identification and Characterization of a Critical CP2-binding Element in the Human Interleukin-4 Promoter Journal of Biological Chemistry ·Vincenzo Casolaro, Andrea Keane‐Myers, Steven Swendeman, Corinna Steindler, Fengming Zhong, M Sheffery, Steve N. Georas, Santa Jeremy Ono	2000	36
17	The effects of serum depletion and dexamethasone on growth and differentiation of human neuroblastoma cell lines Journal of Pediatric Surgery ·Richard D. Glick, Yi-zhi Qian, Daniël C. Aronson, Kathleen W. Scotto, Steven Swendeman, Michael P. LaQuaglia	2000	23
18	Histone deacetylase inhibitors and retinoic acids inhibit growth of human neuroblastoma in vitro Medical and Pediatric Oncology ·Zhibo Qi, Martha C. Kutko, Richard D. Glick, Steven Swendeman, Lisa M. Butler, Richard A. Rifkind, Paul A. Marks, Victoria M. Richon, Michael P. LaQuaglia	2000	48
19	Characterization of the molecularly cloned murine alpha-globin transcription factor CP2. Journal of Biological Chemistry ·L C Lim, Fang Liu, Steven Swendeman, M Sheffery	1993	59
20	Promoter elements and erythroid cell nuclear factors that regulate alpha-globin gene transcription in vitro. Molecular and Cellular Biology ·Chul Geun Kim, Steven Swendeman, Kerry M. Barnhart, M Sheffery	1990	71

About Steven Swendeman

Steven Swendeman is a scholar working on Immunology and Allergy, Ophthalmology, Molecular Biology, Oncology and Cell Biology, having authored 35 papers that have together received 2.6k indexed citations. Recurring topics across this work include Sphingolipid Metabolism and Signaling (10 papers), Genomics and Chromatin Dynamics (5 papers), Retinal Diseases and Treatments (4 papers), DNA and Nucleic Acid Chemistry (4 papers), Neuroblastoma Research and Treatments (3 papers), Cell Adhesion Molecules Research (3 papers), Eicosanoids and Hypertension Pharmacology (2 papers) and Neuroinflammation and Neurodegeneration Mechanisms (2 papers). The work is most often cited by research in Immunology and Allergy (241 citations), Molecular Biology (1.7k citations), Immunology (508 citations), Oncology (599 citations) and Cancer Research (267 citations). Steven Swendeman has collaborated with scholars based in United States, Germany and Japan. Frequent co-authors include David A. Thorley‐Lawson, M Sheffery, Timothy Hla, Carl Blobel, Michael P. LaQuaglia, Victoria A. Blaho, Sylvain Galvani, L C Lim, Hideru Obinata and Richard L. Proia. Their work appears in journals such as Journal of Biological Chemistry, Molecular and Cellular Biology, Science Signaling, Investigative Ophthalmology & Visual Science and Surgery.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact